• In August 2026, Sigma Lithium Corporation raised its multi-year production guidance, bringing forward its 240,000-tonne 2026 target, outlining 330,000 tonnes for 2027 from Plant 1 alone, and confirming plans to complete a third plant by 2028 that would lift total nameplate capacity to 830,000 tonnes per year.
• Over the same period, the company’s quarterly sales and year-to-date results improved markedly, with second-quarter sales rising to US$54.7 million and a much smaller net loss, while the first half of 2026 moved into profitability compared with the prior year’s loss, underscoring progress in turning higher production into earnings.
• Next, we’ll examine how Sigma Lithium’s accelerated 830,000-tonne capacity plan reshapes its previously framed investment narrative and risk balance.

AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Sigma Lithium Investment Narrative Recap

Sigma Lithium’s story still hinges on one big belief: that it can translate low cost, ESG focused Brazilian production into durable cash generation despite volatile lithium prices. The latest guidance upgrade and clearer path to 830,000 tonnes per year sharpen the main near term catalyst, execution at Plant 1 and the next plants, while also amplifying the key risk around timing production ramp ups into uncertain pricing and offtake conditions.

Against that backdrop, the fresh second quarter and first half 2026 results stand out. Sales increased to US$54.7 million in the quarter and to US$97.04 million year to date, with the first half shifting from a loss to profitability. For a volume led growth story, this improving income profile is the most relevant recent data point, because it shows how higher throughput and better unit economics are already flowing through the income statement.

Yet, for all the production ambition, investors should also be aware that any delay or disruption at the Brazilian operations could quickly change how manageable Sigma’s risk profile really is...

Sigma Lithium's narrative projects $600.1 million revenue and $57.4 million earnings by 2028. This implies 64.6% yearly revenue growth and a $105.1 million earnings increase from -$47.7 million today.

Uncover how Sigma Lithium's forecasts yield a $17.17 fair value, a 36% upside to its current price.

Exploring Other Perspectives

Before this news, the most optimistic analysts were banking on revenue reaching about US$534.8 million and earnings of roughly US$419.3 million by 2028, a far more upbeat view than consensus. If you compare that to the current focus on execution risk around the mine and plant ramp up, you can see how much expectations differ and why this latest guidance could push both bullish and cautious narratives to be revisited.

Explore 3 other fair value estimates on Sigma Lithium - why the stock might be worth as much as 57% more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Sigma Lithium research is our analysis highlighting 3 key rewards that could impact your investment decision.
• Our free Sigma Lithium research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Sigma Lithium's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• Outshine the giants: these 18 early-stage AI stocks could fund your retirement.
• This technology could replace computers: discover 24 stocks that are working to make quantum computing a reality.
• Find 46 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.